Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Radiother Oncol. 2013 Feb 28;106(3):383–389. doi: 10.1016/j.radonc.2013.02.001

Figure 4. Expression of tyrosine kinase receptors, activated kinases and EMT markers.

Figure 4

A) Expression of tyrosine kinase receptors (p)HER2, (p)HER3 and (p)MET. B) Expression of kinases (p)AKT, (p-)B-Raf, (p)ERK1/2 and (p)STAT3. C) Expression of EMT markers E-cadherin and vimentin. Expression levels were determined with western blot analysis in 4 SCCNij lines. Two tumors per line were analyzed.